Research suggests that goldenseal and its key active compound berberine have attracted scientific interest for potential antimicrobial properties, though the current evidence base is limited in scope and strength. The available studies include a 2012 narrative review examining berberine's broader health applications, which noted a generally favorable safety profile but did not focus specifically on antimicrobial efficacy, and a 2025 computational study that used virtual screening and molecular simulations to identify goldenseal-derived compounds as promising candidates for inhibiting a critical enzyme in Vibrio cholerae, the bacterium responsible for cholera. While the computational findings are intriguing, this type of in silico research represents an early-stage investigational approach and has not yet been validated through laboratory experiments, animal studies, or human clinical trials. Overall, the existing published evidence for goldenseal as an antimicrobial agent remains preliminary, and well-designed clinical studies would be needed before drawing firm conclusions about its effectiveness in this regard.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Berberine. | Review | 2012 | Neutral | 100 |
| Machine learning-guided in Silico identification of Na⁺-NQR inhibitors from B... | Other | 2025 | Supports | 95 |